145 related articles for article (PubMed ID: 7625304)
21. Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot study.
Tavakkoli F; Nahavandi M; Wyche MQ; Castro O
Clin Ther; 2005 Jul; 27(7):1083-8. PubMed ID: 16154487
[TBL] [Abstract][Full Text] [Related]
22. Comparison of renal function markers in Kuwaiti patients with sickle cell disease.
Marouf R; Mojiminiyi O; Abdella N; Kortom M; Al Wazzan H
J Clin Pathol; 2006 Apr; 59(4):345-51. PubMed ID: 16567469
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for conjunctival and retinal vessel alterations in sickle cell disease.
Lima CS; Rocha EM; Silva NM; Sonatti MF; Costa FF; Saad ST
Acta Ophthalmol Scand; 2006 Apr; 84(2):234-41. PubMed ID: 16637843
[TBL] [Abstract][Full Text] [Related]
24. Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study.
Thompson J; Reid M; Hambleton I; Serjeant GR
Arch Intern Med; 2007 Apr; 167(7):701-8. PubMed ID: 17420429
[TBL] [Abstract][Full Text] [Related]
25. Proteinuria in children with sickle cell disease.
Marsenic O; Couloures KG; Wiley JM
Nephrol Dial Transplant; 2008 Feb; 23(2):715-20. PubMed ID: 18065783
[TBL] [Abstract][Full Text] [Related]
26. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis.
van Tits LJ; van Heerde WL; Landburg PP; Boderie MJ; Muskiet FA; Jacobs N; Duits AJ; Schnog JB
Biochem Biophys Res Commun; 2009 Dec; 390(1):161-4. PubMed ID: 19799864
[TBL] [Abstract][Full Text] [Related]
27. Protein C and S and inflammation in sickle cell disease.
Schnog JB; Mac Gillavry MR; van Zanten AP; Meijers JC; Rojer RA; Duits AJ; ten Cate H; Brandjes DP
Am J Hematol; 2004 May; 76(1):26-32. PubMed ID: 15114593
[TBL] [Abstract][Full Text] [Related]
28. The influence of foetal haemoglobin on the frequency of vaso-occlusive crisis in sickle cell anaemia patients.
Enosolease ME; Ejele OA; Awodu OA
Niger Postgrad Med J; 2005 Jun; 12(2):102-5. PubMed ID: 15997258
[TBL] [Abstract][Full Text] [Related]
29. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.
Ambrusko SJ; Gunawardena S; Sakara A; Windsor B; Lanford L; Michelson P; Krishnamurti L
Pediatr Blood Cancer; 2006 Dec; 47(7):907-13. PubMed ID: 16496290
[TBL] [Abstract][Full Text] [Related]
30. Endogenous creatinine clearance in children with sickle cell anaemia and relationship with age: a preliminary report.
Aikhionbare HA; Suvarnabai PC; Jibril HB
East Afr Med J; 1988 Sep; 65(9):609-13. PubMed ID: 3224570
[No Abstract] [Full Text] [Related]
31. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.
Ogedengbe OK; Akinyanju O
West Afr J Med; 1993; 12(2):96-100. PubMed ID: 8398940
[TBL] [Abstract][Full Text] [Related]
32. Acute splenic sequestration in female children with sickle cell disease in the North of Jordan.
Al-Rimawi HS; Abdul-Qader M; Jallad MF; Amarin ZO
J Trop Pediatr; 2006 Dec; 52(6):416-20. PubMed ID: 16951418
[TBL] [Abstract][Full Text] [Related]
33. Using serial haemorheological parameters to assess clinical status in sickle cell anaemia patients in vaso-occlussive crisis.
Awodu OA; Famodu AA; Ajayi OI; Enosolease ME; Olufemi OY; Olayemi E
Clin Hemorheol Microcirc; 2009; 41(2):143-8. PubMed ID: 19252237
[TBL] [Abstract][Full Text] [Related]
34. Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report.
Ahmed S; Siddiqui AK; Iqbal U; Sison CP; Shahid RK; Sheth M; Patel DV; Russo LA
Eur J Haematol; 2004 Mar; 72(3):213-6. PubMed ID: 14962240
[TBL] [Abstract][Full Text] [Related]
35. Sensorineural hearing loss with brainstem auditory evoked responses changes in homozygote and heterozygote sickle cell patients in Guadeloupe (France).
Jovanovic-Bateman L; Hedreville R
J Laryngol Otol; 2006 Aug; 120(8):627-30. PubMed ID: 16762092
[TBL] [Abstract][Full Text] [Related]
36. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
[TBL] [Abstract][Full Text] [Related]
37. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
Caravaca F; Arrobas M; Luna E; Naranjo M; Pizarro JL; Sánchez-Casado E
Nefrologia; 2002; 22(5):432-7. PubMed ID: 12497744
[TBL] [Abstract][Full Text] [Related]
38. Cardiorenal risk prevalence in sickle cell hemoglobinopathy.
Abo-Zenah H; Moharram M; El Nahas AM
Nephron Clin Pract; 2009; 112(2):c98-c106. PubMed ID: 19390209
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience.
Dehghani SM; Derakhshan A; Taghavi SA; Gholami S; Jalaeian H; Malek-Hosseini SA
Exp Clin Transplant; 2008 Mar; 6(1):25-9. PubMed ID: 18405241
[TBL] [Abstract][Full Text] [Related]
40. The apoptosis of blood polymorphonuclear leukocytes in sickle cell disease.
Ozdogu H; Boga C; Sozer O; Sezgin N; Kizilkilic E; Maytalman E; Yalcintas D
Cytometry B Clin Cytom; 2007 Jul; 72(4):276-80. PubMed ID: 17111385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
